期刊文献+

应用紫外辐射技术灭活血液成分中病原体研究的新进展 被引量:1

Advancements in researches of inactivation of pathogens in blood components by ultraviolet radiation
在线阅读 下载PDF
导出
摘要 确保血液及血液制品的安全,最大限度降低经血传播疾病的风险,一直是世界各国最关心的重大问题.同时,随着各种新方法和新技术的应用,使经血传播病原体的风险得到极大的降低,特别是应用紫外辐射技术灭活血液成分中病原体技术的开展,更进一步降低了经血传播病原体的风险.
出处 《传染病信息》 2005年第1期18-19,共2页 Infectious Disease Information
基金 "十五"课题资助(编号2001BA705B01)
  • 相关文献

参考文献13

  • 1Aubuchon J, Birkmeyer D, Bush M, et al. Cost-effectiveeness of expanded human immunodeficiency virus test protocols for donated blood. Transfusion, 1997,37:45-51
  • 2Schreiber GB, Busch MP, Kleinman SH,et al. The risk of transfusion trasmited viral infections. N Engl J Med, 1996,334 : 1685-1689
  • 3Schutfler GC, Caspari C, Jursch CA,et al. Hepatitis C virus transmission by a blood donation negative in nucleic acid amplification tests for viral RNA. Lancet, 2000,355:41-42
  • 4Rasheed S, Gottlieb AA, Garry RF. Cell killing by ultrviolet-inactivated human immunodeficiency virus. Virology, 1986,154:395-400
  • 5Wugner SJ. Virus inactivation in blood components by photoactive phenothiazine dyes. Transfus Med Rev,2002,16( 1 ) :61-66
  • 6Lambreeht B, Mohr H, Knuver-Hopf J, et al. Photoinaetivation of virus in human flesh plasma by phenothiazine dyes in combination with visible light. Vox Sang, 1999,60:207-213
  • 7周锡鹏 孙萍 许金波.亚甲蓝/光化学方法灭活血浆病毒的光源筛选与比较[J].中国输血杂志,2003,(13):139-140.
  • 8周锡鹏,许金波,孙萍,闫舫,王全立,卜凤荣.亚甲蓝/光化学灭活病毒方法对血浆成分的影响[J].中国实验血液学杂志,2003,11(3):305-307. 被引量:13
  • 9吕丽萍,张艳宇,马平,周锡鹏,姜升阳,许金波.亚甲蓝/光化学法对血浆中IgG的影响[J].中国输血杂志,2004,17(1):8-10. 被引量:5
  • 10Wangner S J, Storry JR, Mallory DA, et al. Red cell membrane alterations associated with virucial methylene blue phototrement. Transfusion, 1992,33:30-36

二级参考文献7

  • 1Sambrook J 金冬雁等(译).分子克隆实验指南[M].北京:科学出版社,1996..
  • 2周锡鹏 孙萍 许金波 等.亚甲蓝/光化学方法灭活血浆病毒的光源筛选与比较[J].中国输血杂志,2000,:139-140.
  • 3李成文.电泳技术[A].见:李成文编著.现代免疫化学技术[C].上海科学技术出版社,1992.52~83.
  • 4刘强远 见:卢圣栋 李尹雄 胡晓年 等编.基因表达产物的检测[A].见:卢圣栋,李尹雄,胡晓年,等编.现代分子生物学实验技术[C].中国协和医科大学出版社,1999.400~403.
  • 5Wagner SJ. Virus inactivation in blood components by photoactive phenothiazine dyes. Transfus Med Rev, 2002; 16:61 -66.
  • 6Mohr H. Virus inactivation of fresh plasma. Vox Sang. 1998; 74(Suppl 2) : 171 - 172.
  • 7周锡鹏,许金波,孙萍,闫舫,王全立,卜凤荣.亚甲蓝/光化学灭活病毒方法对血浆成分的影响[J].中国实验血液学杂志,2003,11(3):305-307. 被引量:13

共引文献16

同被引文献15

  • 1Burnouf T,Radosevich M. Reducing the risk of infection from plasma products:specific preventative strategies[J].Blood Reviews,2000,(02):94-110.
  • 2倪道明.血液制品[M]北京:人民卫生出版社,2013121-123.
  • 3Burnouf T. Modern plasma fractionation[J].Transfusion Medicine Reviews,2007,(02):101-117.
  • 4Roberts PL. Virus inactivation by solvent/detergent treat ment using Triton X-100 in a high purity factor Ⅷ[J].BIOLOGICALS,2008,(05):330-335.
  • 5Roberts PL,Dunkerley C,Walker C. Virus reduction in an intravenous immunoglobulin by solvent/detergent treatment,ion-exchange chromatography and terminal low pH incubation[J].BIOLOGICALS,2012,(05):345-352.
  • 6Lundblad JL,Seng RL. Inactivation of lipid-enveloped viruses in proteins by caprylate[J].VOX SANGUINIS,1991,(02):75-81.
  • 7Dichtelmüller H,Rudnick D,Kloft M. Inactivation of lipid enveloped viruses by octanoic acid treatment of immunoglobulin solution[J].BIOLOGICALS,2002,(02):135-142.
  • 8Chandra S,Groener A,Feldman F. Effectiveness of alternative treatments for reducing potential viral contaminants from plasma-derived products[J].Thrombosis research,2002,(05):301-400.
  • 9Kim IS,Choi YW,Kang Y. Dry-heat treatment process for enhancing viral safety of an antihemophilic factor Ⅷ concentrate prepared from human plasma[J].Journal of Microbiology and Biotechnology,2008,(05):997-1003.
  • 10Caballero S,Nieto S,Gajardo R. Viral safety characteristics of Flebogamma DIF,a new pasteurized,solvent-detergent treated and Planova 20 nm nanofiltered intravenous immunoglobulin[J].BIOLOGICALS,2010,(04):486-493.

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部